Cervical cancer is preventable – yet too many women are diagnosed too late.
50% of cervical cancer cases occur in women who are under- or never-screened.
Screening discomfort + clinic dependence + long gaps delay diagnosis and treatment.
Introducing
Screenher™
Advancing Early Detection
Same-visit, non-invasive cervical screening at the point of care.
Designed for clinics today, scalable for broader access.
Why Now:
Healthcare has shifted. Screening has not.
- Diagnostics are moving toward decentralized, patient-friendly models
- Post-COVID acceptance of self-collection and point-of-care testing has accelerated
- Public health and payers are prioritizing prevention over late-stage treatment
- Women’s health is finally receiving focused investment — yet remains underserved
- Point-of-care diagnostics are clinically accepted and reimbursable in preventive pathway
Global health organizations have prioritized eliminating cervical cancer as a public health problem.
The tools must now match that urgency.
Technology:
ScreenHER is advancing the development of novel, point-of-care screening technology originating from leading academic research.
Mission:
ScreenHER is advancing early detection with a goal of making cervical screening faster, easier, and more accessible.
Stay informed
Enter your email address to stay up to date on the latest ScreenHER news.
Leadership
Jennifer estep
Founder and CEO
Jennifer is a Purdue-trained mechanical engineer and experienced medtech commercialization leader who has scaled venture-backed medical device platforms from early development through IPO-ready growth.
She founded ScreenHER to bring patient-centered design, operational rigor, and real-world scalability to women’s health diagnostics—advancing earlier detection and expanding access to preventive care globally.
